AMPLITUDE is the first clinical trial to evaluate potential therapies for patients with mHSPC and known HRR gene alterations, with positive results supporting the niraparib-based combination regimen a ...
Rare earth stocks are surging as U.S. policy shifts and China asserts itself. Here are five rare-earth stocks poised to ...
Sagimet Biosciences dropped 9% after Ascletis Pharma’s Phase 3 Denifanstat safety data focused on tolerability, not new ...
Elementis’s overall stock score is driven by strong technical momentum and positive corporate actions like share buybacks and strategic acquisitions. However, financial performance is mixed with ...
Onvansertib added to FOLFIRI/bev first-line standard of care regimen showed dose-dependent improvement in overall response rates and durability trends as measured by progression-free survival in patie ...
Metallurgical testing is underway, and we have started the process of developing a mine plan around the higher-grade ...
All amounts are in United States dollars, unless otherwise stated TORONTO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Alamos Gold Inc.
Saturday horse racing tips cheat sheet for ITV racing at Leopardstown, Musselburgh and Sandown plus Paul Nicholls exclusive runners preview ...
International Paper Company (NYSE:IP) Q4 2025 Earnings Call Transcript January 29, 2026 International Paper Company misses on earnings expectations. Reported EPS is $-0.08 EPS, expectations were $0.28 ...
White Falcon reports a 25.9% three-year annualized return, highlighting portfolio performance driven by core holdings in AMD ...
Onvansertib added to FOLFIRI/bev first-line standard of care regimen showed dose-dependent improvement in overall response rates and durability trends as measured by progression-free survival in patie ...
Media ReleaseEntered into strategic collaboration with Dr. Reddy’s for commercialisation of eftilagimod alfa (efti) in all countries outside ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results